Trial Profile
The evaluation of sitagliptin on proteinuria in diabetic patient with nephropathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Feb 2018 Status changed from recruiting to completed.
- 21 Dec 2017 New trial record